GeneTools

Gene Tools is a pioneering developer and supplier of Morpholino antisense oligos, a stable and specific RNA-targeting technology used extensively in academic research, drug discovery, and target validation. While the company itself is not a drug developer, its foundational technology platform has enabled multiple FDA-approved therapeutics for genetic disorders, such as Duchenne muscular dystrophy (e.g., eteplirsen). Gene Tools distinguishes itself through deep scientific customer support, a vast publication record, and continuous innovation in oligo delivery systems like Endo-Porter and Vivo-Morpholinos for cell culture and in vivo applications.

Morpholino antisense oligonucleotides: synthetic nucleic acid analogs with a methylenemorpholine backbone and phosphorodiamidate linkages that sterically block RNA function with high specificity and stability, used for gene knockdown, splice modulation, and miRNA inhibition.

Gene Tools competes in the research tools market against large oligo suppliers (e.g., IDT, Sigma) offering siRNAs and CRISPR guides, and in the therapeutic oligonucleotide space against companies using phosphorothioate ASOs (Ionis, Biogen), siRNA (Alnylam), and other chemistries. Its key differentiation is Morpholino's unique steric-blocking mechanism and proven specificity.